5 papers found
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic ProfileDownload from doi.org
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple MyelomaDownload from doi.org
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systemsUpload
Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete responseUpload
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre studyUpload
Missing publications? Search for publications with a matching author name.